{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Glucagon receptor antagonist compounds", "item": "https://www.patentleaderboard.com/patent/8445538"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glucagon receptor antagonist compounds

Glucagon receptor antagonist compounds

US Patent 8445538 · Granted May 21, 2013

Estimated economic value: $71,313,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bruton's tyrosine kinase inhibitors2025
Glucose-responsive insulin conjugates2025
Bruton's tyrosine kinase inhibitors2024
Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc2023
Conjugate based systems for controlled insulin delivery2023
Bruton's tyrosine kinase inhibitors2023
6-mercaptopurine nucleoside analogues2022
Tyrosine-specific functionalized insulin and insulin analogs2022
Conjugate based systems for controlled insulin delivery2022
JAK inhibitors2022
Methods of treating diabetes by administering a glucagon receptor antagonist in 2021
Insulin dimer-incretin conjugates2021